Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11767317 Methods of synthesizing enantiopure deuterium-enriched pioglitazone

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Inventor Names

Vincent Jacques

Sébastien Bolze

Laure Françoise Valérie Navarre

Date of Patent

September 26, 2023

Patent Application Number

17360315

Date Filed

June 28, 2021

Patent Citations

US Patent 8236786 Respiratory disease treatment

US Patent 8263631 Anti-cancer pharmaceutical compositions and methods for treating patients with cancer

US Patent 8389556 Thiazolidinedione analogues

US Patent 8722710 Deuterium-enriched pioglitazone

US Patent 8969581 5-deutero-2,4-thiazolidinedione derivatives and compositions comprising and methods of using the same

US Patent 9123444 Method of testing coherency of data storage in multi-processor shared memory system

US Patent 9416117 5-deutero-2,4-thiazolidinedione derivatives and compositions comprising and methods of using the same

US Patent 9782395 2,4-thiazolidinedione derivatives in the treatment of central nervous system disorders

...

Patent Primary Examiner

Matthew P Coughlin

CPC Code

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11767317 Methods of synthesizing enantiopure deuterium-enriched pioglitazone

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool